The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Open accessAbstract
The use of nanoparticulate pharmaceutical drug delivery systems (NDDSs) to enhance the in vivo effectiveness of drugs is now well established. The development of multifunctional and stimulus-sensitive NDDSs is an active area of current research. Such NDDSs can have long circulation times, target the site of the disease and enhance the intracellular delivery of a drug. This type of NDDS can also respond to local stimuli that are characteristic of the pathological site by, for example, releasing an entrapped drug or shedding a protective coating, thus facilitating the interaction between drug-loaded nanocarriers and target cells or tissues. In addition, imaging contrast moieties can be attached to these carriers to track their real-time biodistribution and accumulation in target cells or tissues. Here, I highlight recent developments with multifunctional and stimuli-sensitive NDDSs and their therapeutic potential for diseases including cancer, cardiovascular diseases and infectious diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Shape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Self-citationAmphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
Self-citationNew-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Targeted drug delivery to tumors: Myths, reality and possibility
Bae, Y. H., & Park, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.001 · Cited by 1,935
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Gialeli, C., Theocharis, A. D., & Karamanos, N. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07919.x · Cited by 1,607
Exchange-coupled magnetic nanoparticles for efficient heat induction
Lee, J.-H., Jang, J.-T., Choi, J.-S., Moon, S. H., Noh, S.-H., Kim, J.-W., Kim, J.-G., Kim, I.-S., Park, K. I., & Cheon, J. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.95 · Cited by 1,364
PEG-modified gold nanorods with a stealth character for in vivo applications
Niidome, T., Yamagata, M., Okamoto, Y., Akiyama, Y., Takahashi, H., Kawano, T., Katayama, Y., & Niidome, Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.017 · Cited by 1,200
Low, P. S., Henne, W. A., & Doorneweerd, D. D. (2008) · Accounts of Chemical Research · doi:10.1021/ar7000815 · Cited by 1,173
Molecular imaging in drug development
Willmann, J. K., van Bruggen, N., Dinkelborg, L. M., & Gambhir, S. S. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2290 · Cited by 1,171
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Wong, C., Stylianopoulos, T., Cui, J., Martin, J., Chauhan, V. P., Jiang, W., Popović, Z., Jain, R. K., Bawendi, M. G., & Fukumura, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018382108 · Cited by 1,062
Computationally Guided Photothermal Tumor Therapy Using Long-Circulating Gold Nanorod Antennas
von Maltzahn, G., Park, J.-H., Agrawal, A., Bandaru, N. K., Das, S. K., Sailor, M. J., & Bhatia, S. N. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4242 · Cited by 1,051
Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects
Maeda, H. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100070g · Cited by 998
Folate-mediated delivery of macromolecular anticancer therapeutic agents
Lu, Y., & Low, P. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00042-x · Cited by 941
High-Efficiency Intracellular Magnetic Labeling with Novel Superparamagnetic-Tat Peptide Conjugates
Josephson, L., Tung, C.-H., Moore, A., & Weissleder, R. (1999) · Bioconjugate Chemistry · doi:10.1021/bc980125h · Cited by 882
Bartlett, D. W., Su, H., Hildebrandt, I. J., Weber, W. A., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707461104 · Cited by 803
The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer
Farhood, H., Serbina, N., & Huang, L. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)80016-9 · Cited by 798
Torchilin, V. P., Rammohan, R., Weissig, V., & Levchenko, T. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151247498 · Cited by 777
Self-citationIn vivo imaging of siRNA delivery and silencing in tumors
Medarova, Z., Pham, W., Farrar, C., Petkova, V., & Moore, A. (2007) · Nature Medicine · doi:10.1038/nm1486 · Cited by 697
Transport of Molecules, Particles, and Cells in Solid Tumors
Jain, R. K. (1999) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.1.1.241 · Cited by 691
Batist, G., Ramakrishnan, G., Rao, C. S., Chandrasekharan, A., Gutheil, J., Guthrie, T., Shah, P., Khojasteh, A., Nair, M. K., Hoelzer, K., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1444 · Cited by 669
Multifunctional and stimuli-sensitive pharmaceutical nanocarriers
Torchilin, V. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.026 · Cited by 583
Self-citationSurface-Engineered Magnetic Nanoparticle Platforms for Cancer Imaging and Therapy
Xie, J., Liu, G., Eden, H. S., Ai, H., & Chen, X. (2011) · Accounts of Chemical Research · doi:10.1021/ar200044b · Cited by 582
Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro
Lee, R. J., & Low, P. S. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)00235-h · Cited by 574
Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy
Parhi, P., Mohanty, C., & Sahoo, S. K. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.05.010 · Cited by 573
Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
Wojtkowiak, J. W., Verduzco, D., Schramm, K. J., & Gillies, R. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200292c · Cited by 566
Ishida, T., Ichihara, M., Wang, X., Yamamoto, K., Kimura, J., Majima, E., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.005 · Cited by 557
“SMART” Drug Delivery Systems: Double-Targeted pH-Responsive Pharmaceutical Nanocarriers
Sawant, R. M., Hurley, J. P., Salmaso, S., Kale, A., Tolcheva, E., Levchenko, T. S., & Torchilin, V. P. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060080h · Cited by 540
Self-citationCancer nanomedicines: So many papers and so few drugs!
Venditto, V. J., & Szoka, F. C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.038 · Cited by 537
Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
Chen, Y., Zhu, X., Zhang, X., Liu, B., & Huang, L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.136 · Cited by 515
Zhu, L., Kate, P., & Torchilin, V. P. (2012) · ACS Nano · doi:10.1021/nn300524f · Cited by 489
Self-citationSilverman, J. A., & Deitcher, S. R. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-2042-4 · Cited by 474
Liposome-based drug delivery in breast cancer treatment
Park, J. W. (2002) · Breast Cancer Research · doi:10.1186/bcr432 · Cited by 469
Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy
Pradhan, P., Giri, J., Rieken, F., Koch, C., Mykhaylyk, O., Döblinger, M., Banerjee, R., Bahadur, D., & Plank, C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.002 · Cited by 468
Gabizon, A. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.011 · Cited by 464
Schipper, M. L., Iyer, G., Koh, A. L., Cheng, Z., Ebenstein, Y., Aharoni, A., Keren, S., Bentolila, L. A., Li, J., Rao, J., et al. (2009) · Small · doi:10.1002/smll.200800003 · Cited by 452
Poly(l-histidine)–PEG block copolymer micelles and pH-induced destabilization
Lee, E. S., Shin, H. J., Na, K., & Bae, Y. H. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00205-0 · Cited by 451
Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes
Torchilin, V. P., Levchenko, T. S., Rammohan, R., Volodina, N., Papahadjopoulos-Sternberg, B., & D'Souza, G. G. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0435906100 · Cited by 419
Self-citationAcid production in glycolysis-impaired tumors provides new insights into tumor metabolism.
Helmlinger, G., Sckell, A., Dellian, M., Forbes, N. S., & Jain, R. K. (2002) · PubMed · Cited by 417
Xiong, X.-B., & Lavasanifar, A. (2011) · ACS Nano · doi:10.1021/nn2013707 · Cited by 411
Challenges in Development of Targeted Liposomal Therapeutics
Sawant, R. R., & Torchilin, V. P. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9330-0 · Cited by 379
Self-citationMonsky, W. L., Fukumura, D., Gohongi, T., Ancukiewcz, M., Weich, H. A., Torchilin, V. P., Yuan, F., & Jain, R. K. (1999) · PubMed · Cited by 368
Self-citationHu, K., Li, J., Shen, Y., Lu, W., Gao, X., Zhang, Q., & Jiang, X. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.016 · Cited by 354
Multi-functional polymeric nanoparticles for tumour-targeted drug delivery
van Vlerken, L. E., & Amiji, M. M. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.2.205 · Cited by 352
Sherlock, S. P., Tabakman, S. M., Xie, L., & Dai, H. (2011) · ACS Nano · doi:10.1021/nn103415x · Cited by 346
Kim, D., Lee, E. S., Oh, K. T., Gao, Z. G., & Bae, Y. H. (2008) · Small · doi:10.1002/smll.200701275 · Cited by 313
Ultrasound triggered release of cisplatin from liposomes in murine tumors
Schroeder, A., Honen, R., Turjeman, K., Gabizon, A., Kost, J., & Barenholz, Y. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.007 · Cited by 305
Mitochondrial gateways to cancer
Galluzzi, L., Morselli, E., Kepp, O., Vitale, I., Rigoni, A., Vacchelli, E., Michaud, M., Zischka, H., Castedo, M., & Kroemer, G. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.08.002 · Cited by 300
Bacteria‐Responsive Multifunctional Nanogel for Targeted Antibiotic Delivery
Xiong, M., Li, Y., Bao, Y., Yang, X., Hu, B., & Wang, J. (2012) · Advanced Materials · doi:10.1002/adma.201202847 · Cited by 299
Koren, E., Apte, A., Jani, A., & Torchilin, V. P. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.002 · Cited by 293
Self-citationNear-Infrared Light-Responsive Core–Shell Nanogels for Targeted Drug Delivery
Kang, H., Trondoli, A. C., Zhu, G., Chen, Y., Chang, Y.-J., Liu, H., Huang, Y.-F., Zhang, X., & Tan, W. (2011) · ACS Nano · doi:10.1021/nn201171r · Cited by 288
Ishida, T., Atobe, K., Wang, X., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.017 · Cited by 287
Inhibition of melanoma tumor growth in vivo by survivin targeting
Grossman, D., Kim, P. J., Schechner, J. S., & Altieri, D. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.635 · Cited by 286
Eck, W., Craig, G., Sigdel, A., Ritter, G., Old, L. J., Tang, L., Brennan, M. F., Allen, P. J., & Mason, M. D. (2008) · ACS Nano · doi:10.1021/nn800429d · Cited by 280
Newman, M. S., Colbern, G. T., Working, P. K., Engbers, C., & Amantea, M. A. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050855 · Cited by 275
Targeted delivery of doxorubicin using stealth liposomes modified with transferrin
Li, X., Ding, L., Xu, Y., Wang, Y., & Ping, Q. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.01.023 · Cited by 274
Torchilin, V. P., Levchenko, T. S., Lukyanov, A. N., Khaw, B. A., Klibanov, A. L., Rammohan, R., Samokhin, G. P., & Whiteman, K. R. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2728(01)00165-7 · Cited by 271
Self-citationMagnetic Iron Oxide Nanoparticles for Multimodal Imaging and Therapy of Cancer
Thomas, R., Park, I.-K., & Jeong, Y. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140815910 · Cited by 271
Targeting atherosclerosis by using modular, multifunctional micelles
Peters, D., Kastantin, M., Kotamraju, V. R., Karmali, P. P., Gujraty, K., Tirrell, M., & Ruoslahti, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903369106 · Cited by 271
Wang, T., Upponi, J. R., & Torchilin, V. P. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.07.013 · Cited by 268
Self-citationpH and Reduction Dual-Sensitive Copolymeric Micelles for Intracellular Doxorubicin Delivery
Chen, J., Qiu, X., Ouyang, J., Kong, J., Zhong, W., & Xing, M. M. Q. (2011) · Biomacromolecules · doi:10.1021/bm200804j · Cited by 259
Stimulus-responsive nanopreparations for tumor targeting
Zhu, L., & Torchilin, V. P. (2013) · Integrative Biology · doi:10.1039/c2ib20135f · Cited by 258
Self-citationMultifunctional dendrimer-entrapped gold nanoparticles for dual mode CT/MR imaging applications
Wen, S., Li, K., Cai, H., Chen, Q., Shen, M., Huang, Y., Peng, C., Hou, W., Zhu, M., Zhang, G., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.010 · Cited by 257
Sajja, H., East, M., Mao, H., Wang, Y., Nie, S., & Yang, L. (2009) · Current Drug Discovery Technologies · doi:10.2174/157016309787581066 · Cited by 250
Nanoparticulates as Drug Carriers
Torchilin, V. P. (2006) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/p432 · Cited by 248
Self-citationTseng, Y.-L., Liu, J.-J., & Hong, R.-L. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.4.864 · Cited by 241
Kale, A. A., & Torchilin, V. P. (2007) · Bioconjugate Chemistry · doi:10.1021/bc060228x · Cited by 228
Self-citationLipoplatin Formulation Review Article
Stathopoulos, G. P., & Boulikas, T. (2012) · Journal of Drug Delivery · doi:10.1155/2012/581363 · Cited by 224
Poly(amidoamine) dendrimer–drug conjugates with disulfide linkages for intracellular drug delivery
Kurtoglu, Y. E., Navath, R. S., Wang, B., Kannan, S., Romero, R., & Kannan, R. M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.054 · Cited by 224
Amphiphilic poly-N-vinylpyrrolidones:
Torchilin, V. P., Levchenko, T. S., Whiteman, K. R., Yaroslavov, A. A., Tsatsakis, A. M., Rizos, A. K., Michailova, E. V., & Shtilman, M. I. (2001) · Biomaterials · doi:10.1016/s0142-9612(01)00050-3 · Cited by 214
Self-citationReceptor-Targeted Nanoparticles for In vivo Imaging of Breast Cancer
Yang, L., Peng, X.-H., Wang, Y. A., Wang, X., Cao, Z., Ni, C., Karna, P., Zhang, X., Wood, W. C., Gao, X., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3289 · Cited by 213
Batist, G., Gelmon, K. A., Chi, K. N., Miller, W. H., Chia, S. K. L., Mayer, L. D., Swenson, C. E., Janoff, A. S., & Louie, A. C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0515 · Cited by 213
Sun, C., Fang, C., Stephen, Z., Veiseh, O., Hansen, S., Lee, D., Ellenbogen, R. G., Olson, J., & Zhang, M. (2008) · Nanomedicine · doi:10.2217/17435889.3.4.495 · Cited by 213
Maksimenko, A., Dosio, F., Mougin, J., Ferrero, A., Wack, S., Reddy, L. H., Weyn, A.-A., Lepeltier, E., Bourgaux, C., Stella, B., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313459110 · Cited by 212
Yang, X., Grailer, J. J., Pilla, S., Steeber, D. A., & Gong, S. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900422j · Cited by 206
Takeuchi, H., Kojima, H., Yamamoto, H., & Kawashima, Y. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00368-6 · Cited by 205
Efficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNA
Li, S.-D., Chono, S., & Huang, L. (2008) · Molecular Therapy · doi:10.1038/mt.2008.51 · Cited by 198
Banerjee, M., Mallick, S., Paul, A., Chattopadhyay, A., & Ghosh, S. S. (2010) · Langmuir · doi:10.1021/la9038528 · Cited by 196
Kim, D., Gao, Z. G., Lee, E. S., & Bae, Y. H. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900021q · Cited by 183
In vivo tumor diagnosis and photodynamic therapy via tumoral pH-responsive polymeric micelles
Koo, H., Lee, H., Lee, S., Min, K. H., Kim, M. S., Lee, D. S., Choi, Y., Kwon, I. C., Kim, K., & Jeong, S. Y. (2010) · Chemical Communications · doi:10.1039/c0cc01413c · Cited by 180
Nagamitsu, A., Greish, K., & Maeda, H. (2009) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp074 · Cited by 180
Nanoparticulate Drug Delivery Systems
(2007) · CRC Press eBooks · doi:10.1201/9781420008449 · Cited by 171
Navarro, G., Sawant, R. R., Biswas, S., Essex, S., Tros de Ilarduya, C., & Torchilin, V. P. (2012) · Nanomedicine · doi:10.2217/nnm.11.93 · Cited by 170
Self-citationChen, K.-J., Chaung, E.-Y., Wey, S.-P., Lin, K.-J., Cheng, F., Lin, C.-C., Liu, H.-L., Tseng, H.-W., Liu, C.-P., Wei, M.-C., et al. (2014) · ACS Nano · doi:10.1021/nn501162x · Cited by 170
A liposome-based nanostructure for aptamer directed delivery
Kang, H., O’Donoghue, M. B., Liu, H., & Tan, W. (2010) · Chem. Commun. · doi:10.1039/b916911c · Cited by 169
Li, S., Goins, B., Zhang, L., & Bao, A. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300175d · Cited by 168
Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes
Hatakeyama, H., Akita, H., Ishida, E., Hashimoto, K., Kobayashi, H., Aoki, T., Yasuda, J., Obata, K., Kikuchi, H., Ishida, T., et al. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.04.037 · Cited by 165
Image-Guided Breast Tumor Therapy Using a Small Interfering RNA Nanodrug
Kumar, M., Yigit, M., Dai, G., Moore, A., & Medarova, Z. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2070 · Cited by 164
Droumaguet, B. L., Nicolas, J., Brambilla, D., Mura, S., Maksimenko, A., Kimpe, L. D., Salvati, E., Zona, C., Airoldi, C., Canovi, M., et al. (2012) · ACS Nano · doi:10.1021/nn3004372 · Cited by 160
Enzyme-activated targeting of liposomes
Meers, P. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00205-8 · Cited by 160
Localised drug release using MRI-controlled focused ultrasound hyperthermia
Staruch, R., Chopra, R., & Hynynen, K. (2011) · International Journal of Hyperthermia · doi:10.3109/02656736.2010.518198 · Cited by 159
Kale, A. A., & Torchilin, V. P. (2007) · Journal of Drug Targeting · doi:10.1080/10611860701498203 · Cited by 159
Self-citationTowards more effective advanced drug delivery systems1
Crommelin, D. J. A., & Florence, A. T. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.020 · Cited by 158
VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo
Gosk, S., Moos, T., Gottstein, C., & Bendas, G. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.12.021 · Cited by 158
Needham, D., Park, J.-Y., Wright, A. M., & Tong, J. (2012) · Faraday Discussions · doi:10.1039/c2fd20111a · Cited by 148
Kim, I., Kang, Y., Lee, D. S., Park, H. J., Choi, E., Oh, Y., Son, H.-J., & Kim, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.07.005 · Cited by 147
Rodriguez, M. A., Pytlík, R., Kozák, T., Chhanabhai, M., Gascoyne, R. D., Lu, B., Deitcher, S. R., & Winter, J. N. (2009) · Cancer · doi:10.1002/cncr.24359 · Cited by 145
Sarris, A. H., Hagemeister, F. B., Romaguera, J. E., Rodríguez, M., McLaughlin, P. J., Tsimberidou, A. M., Medeiros, L. J., Samuels, B. I., Pate, O., Oholendt, M. S., et al. (2000) · Annals of Oncology · doi:10.1023/a:1008348010437 · Cited by 143
Basel, M. T., Shrestha, T. B., Troyer, D. L., & Bossmann, S. H. (2011) · ACS Nano · doi:10.1021/nn103362n · Cited by 141
Kaminskas, L. M., Kelly, B. D., McLeod, V. M., Boyd, B. J., Krippner, G. Y., Williams, E. D., & Porter, C. J. H. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900049a · Cited by 139
Molecular imaging of macrophages in atherosclerotic plaques using bimodal PEG‐micelles
Mulder, W. J. M., Strijkers, G. J., Briley-Saebo, K. C., Frias, J. C., Aguinaldo, J. G. S., Vucic, E., Amirbekian, V., Tang, C. Y., Chin, P. T. K., Nicolay, K., et al. (2007) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21315 · Cited by 138
Dong, D., Xiang, B., Gao, W., Yang, Z., Li, J., & Qi, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.018 · Cited by 130
Nanocarriers for Nuclear Imaging and Radiotherapy of Cancer
Mitra, A., Nan, A., Line, B. R., et al. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206779026317 · Cited by 130
Liposomal daunorubicin as treatment for Kaposi’s sarcoma
Dittmer, D. P., & Petre, C. E. (2007) · PubMed Central · doi:10.17615/wyf0-9n94 · Cited by 130
Wang, W., Xiong, W., Wan, J., Sun, X., Xu, H., & Yang, X. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/10/105103 · Cited by 129
Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging
Fang, J., Wen, C.-J., Zhang, Z., Al-Suwayeh, & Yen, T. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29369 · Cited by 126
Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery
Sawant, R. R., Sriraman, S. K., Navarro, G., Biswas, S., Dalvi, R. A., & Torchilin, V. P. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.088 · Cited by 119
Self-citationMihu, M. R., Sandkovsky, U., Han, G., Friedman, J. M., Nosanchuk, J. D., & Martinez, L. R. (2010) · Virulence · doi:10.4161/viru.1.2.10038 · Cited by 118
Challenges and opportunities in the advancement of nanomedicines
Wei, A., Mehtala, J. G., & Patri, A. K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.10.007 · Cited by 117
Gabizón, A., Tzemach, D., Gorin, J., Mak, L., Amitay, Y., Shmeeda, H., & Zalipsky, S. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1132-4 · Cited by 116
Sasaki, K., Kogure, K., Chaki, S., Nakamura, Y., Moriguchi, R., Hamada, H., Danev, R., Nagayama, K., Futaki, S., & Harashima, H. (2008) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-008-2012-1 · Cited by 115
Zheng, J., Liu, J., Dunne, M., Jaffray, D. A., & Allen, C. J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9220-1 · Cited by 115
Lee, P.-W., Hsu, S., Tsai, J.-S., Chen, F., Huang, P.-J., Ke, C., Liao, Z.-X., Hsiao, C., Lin, H.-J., & Sung, H. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.100 · Cited by 112
Antiangiogenic Targeting Liposomes Increase Therapeutic Efficacy for Solid Tumors
Chang, D.-K., Chiu, C., Kuo, S.-Y., Lin, W.-C., Lo, A., Wang, Y., Li, P., & Wu, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900280200 · Cited by 109
Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancer.
Seetharamu, N., Kim, E., Höchster, H. S., Martin, F., & Muggia, F. M. (2010) · PubMed · Cited by 107
ElBayoumi, T. A., & Torchilin, V. P. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.05.113 · Cited by 106
Self-citationElBayoumi, T. A., & Torchilin, V. P. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0139-x · Cited by 104
Self-citationMultifunctional drug delivery system for targeting tumor and its acidic microenvironment
Shen, M., Huang, Y., Han, L., Qin, J., Fang, X., Wang, J., & Yang, V. C.-M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.013 · Cited by 103
Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes
Zhu, L., Huo, Z., Wang, L., Tong, X., Xiao, Y. Z., & Ni, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.12.003 · Cited by 102
Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
Stathopoulos, G. P., Antoniou, D., Dimitroulis, J., Stathopoulos, J., Marosis, K., & Michalopoulou, P. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1572-5 · Cited by 102
Shim, G., Han, S.-E., Yu, Y.-H., Lee, S. B., Lee, H. Y., Kim, K., Kwon, I. C., Park, T. G., Kim, Y. B., Choi, Y. S., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.017 · Cited by 101
Gløgård, C., Stensrud, G., Hovland, R., Fossheim, S. L., & Klaveness, J. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00935-8 · Cited by 101
Semple, S. C., Leone, R., Wang, J., Leng, E. C., Klimuk, S. K., Eisenhardt, M. L., Yuan, Z.-N., Edwards, K., Maurer, N., Hope, M. J., et al. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20332 · Cited by 101
Grange, C., Crich, S. G., Esposito, G., Alberti, D., Tei, L., Bussolati, B., Aime, S., & Camussi, G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2821 · Cited by 101
Fasol, U., Frost, A., Büchert, M., Arends, J., Fiedler, U., Scharr, D., Scheuenpflug, J., & Mross, K. B. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr300 · Cited by 101
WICKI, A. N., Rochlitz, C. F., Orleth, A., Ritschard, R., Albrecht, I., Herrmann, R., Christofori, G., & Mamot, C. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1102 · Cited by 101
Poon, R. T. P., & Borys, N. (2011) · Future Oncology · doi:10.2217/fon.11.73 · Cited by 100
Trubetskoy, V. S., Cannillo, J. A., Milshtein, A., Wolf, G. L., & Torchilin, V. P. (1995) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(94)00083-f · Cited by 98
Self-citationKenny, G. D., Kamaly, N., Kalber, T. L., Brody, L., Sahuri-Arisoylu, M., Shamsaei, E., Miller, A. D., & Bell, J. D. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.09.020 · Cited by 97
Liao, C., Sun, Q., Liang, B., Shen, J., & Shuai, X. (2010) · European Journal of Radiology · doi:10.1016/j.ejrad.2010.08.005 · Cited by 96
VEGF siRNA Delivery System Using Arginine-Grafted Bioreducible Poly(disulfide amine)
Kim, S. H., Jeong, J. H., Kim, T., Kim, S. W., & Bull, D. A. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800161e · Cited by 94
Musacchio, T., Vaze, O. S., D’Souza, G. G. M., & Torchilin, V. P. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100199c · Cited by 94
Self-citationRecent advances in ligand targeted therapy
Trapani, G., Denora, N., Trapani, A., & Laquintana, V. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2011.611518 · Cited by 94
A clinical study on the premedication of paclitaxel liposome in the treatment of solid tumors
Zhang, Q., Huang, X., & Gao, L. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.10.001 · Cited by 93
POLY(HPMA)-COATED LIPOSOMES DEMONSTRATE PROLONGED CIRCULATION IN MICE
Whiteman, K. R., Šubr, V., Ulbrich, K., & Torchilin, V. P. (2001) · Journal of Liposome Research · doi:10.1081/lpr-100108459 · Cited by 93
Self-citationKoshkaryev, A., Piroyan, A., & Torchilin, V. P. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.13.1.18871 · Cited by 92
Self-citationEarly cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation
de Jonge, M. J. A., Slingerland, M., Loos, W. J., Wiemer, E. A. C., Burger, H., Mathijssen, R. H. J., Kroep, J. R., den Hollander, M., van der Biessen, D. A. J., Lam, M.-H., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.015 · Cited by 92
Treatment of Acute Lymphoblastic Leukaemia
Apostolidou, E., Swords, R. T., Alvarado, Y., & Giles, F. J. (2007) · Drugs · doi:10.2165/00003495-200767150-00004 · Cited by 91
Targeted Delivery of siRNA to Hepatocytes and Hepatic Stellate Cells by Bioconjugation
Zhu, L., & Mahato, R. I. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100346n · Cited by 91
Chou, H., Wang, K., Chen, C., Wei, L., Lai, C., Hsieh, C., Yang, Y., Twu, N.-F., Chang, T., & Yen, M. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.10.027 · Cited by 90
Gupta, B., & Torchilin, V. P. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0273-0 · Cited by 89
Self-citationA Novel Nested Liposome Drug Delivery Vehicle Capable of Ultrasound Triggered Release of its Payload
Ibsen, S., Benchimol, M. J., Simberg, D., Schutt, C. E., Steiner, J., & Esener, S. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.032 · Cited by 89
Slingerland, M., Guchelaar, H., Rosing, H., Scheulen, M. E., van Warmerdam, L. J. C., Beijnen, J. H., & Gelderblom, H. A. J. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.10.009 · Cited by 89
Nanomedicine for the prevention, treatment and imaging of atherosclerosis
Psarros, C. T., Lee, R., Margaritis, M., & Antoniades, C. A. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.05.006 · Cited by 89
Targeted Multifunctional Lipid-Based Nanocarriers for Image-Guided Drug Delivery
Koning, G. A., & Krijger, G. C. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007781058613 · Cited by 86
Biswas, S., Dodwadkar, N. S., Sawant, R. R., Koshkaryev, A., & Torchilin, V. P. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2010.536983 · Cited by 86
Self-citationUse of nanoscale delivery systems to maintain synergistic drug ratiosin vivo
Dicko, A., Mayer, L. D., & Tardi, P. G. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.538678 · Cited by 86
Brož, P., Ben-Haim, N., Grzelakowski, M., Marsch, S. C. U., Meier, W. P., & Hunziker, P. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181624aed · Cited by 84
Silica-Antibiotic Hybrid Nanoparticles for Targeting Intracellular Pathogens
Seleem, M. N., Munusamy, P., Ranjan, A., Alqublan, H., Pickrell, G., & Sriranganathan, N. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00815-09 · Cited by 84
Mitchell, N., Kalber, T. L., Cooper, M. S., Sunassee, K., Chalker, S. L., Shaw, K., Ordidge, K., Badar, A., Janes, S. M., Blower, P. J., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.070 · Cited by 84
Multifunctional Nanoagent for Thrombus-Targeted Fibrinolytic Therapy
McCarthy, J. R., Sazonova, I. Y., Erdem, S. S., Hara, T., Thompson, B. D., Patel, P., Botnaru, I., Lin, C. P., Reed, G. L., Weissleder, R., et al. (2012) · Nanomedicine · doi:10.2217/nnm.11.179 · Cited by 81
Biswas, S., Dodwadkar, N. S., Deshpande, P. P., Parab, S., & Torchilin, V. P. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.12.021 · Cited by 81
Self-citationVerma, D. D., Hartner, W. C., Thakkar, V., Levchenko, T. S., & Torchilin, V. P. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9334-0 · Cited by 79
Self-citationTwo‐Photon‐Sensitive and Sugar‐Targeted Nanocarriers from Degradable and Dendritic Amphiphiles
Sun, L., Yang, Y., Dong, C., & Wei, Y. (2010) · Small · doi:10.1002/smll.201001729 · Cited by 79
Yudina, A., de Smet, M., Lepetit‐Coiffé, M., Langereis, S., Ruijssevelt, L. V., Смирнов, П. В., Bouchaud, V., Voisin, P. J., Grüll, H., & MOONEN, C. T. W. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.006 · Cited by 79
Pal, A., Khan, S., Wang, Y.-F., Kamath, N., Sarkar, A., Ahmad, A., Sheikh, S., Ali, S., Carbonaro, D., Zhang, A., et al. (2005) · PubMed · Cited by 79
Liu, J., He, W., Zhang, L., Zhang, Z., Zhu, J., Yuan, L., Chen, H., Cheng, Z., & Zhu, X. (2011) · Langmuir · doi:10.1021/la202749v · Cited by 78
Nanoparticle delivery of a peptide targeting EGFR signaling
Kim, S. K., & Huang, L. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.014 · Cited by 75
Erdoğan, S., Medarova, Z. O., Roby, A., Moore, A. V., & Torchilin, V. P. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21202 · Cited by 74
Self-citationTumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomes
Gao, J., Zhong, W. H., He, J., Li, H., Zhang, H., Zhou, G., Li, B., Lü, Y., Zou, H. L., Kou, G., et al. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.03.018 · Cited by 71
Guo, Y., Chen, W., Wang, W., Shen, J., Guo, R., Gong, F., Lin, S., Cheng, D., Chen, G., & Shuai, X. (2012) · ACS Nano · doi:10.1021/nn3037573 · Cited by 69
ElBayoumi, T. A., & Torchilin, V. P. (2008) · Molecular Pharmaceutics · doi:10.1021/mp8001528 · Cited by 68
Self-citationRiviere, K., Huang, Z. R., Jerger, K., Macaraeg, N., & Szoka, F. C. (2010) · Journal of drug targeting · doi:10.3109/10611861003733953 · Cited by 68
Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer
Booser, D. J., Esteva, F. J., Rivera, E., Valero, V., Esparza-Guerra, L., Priebe, W., & Hortobágyi, G. N. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0464-0 · Cited by 67
Goldenbogen, B., Brodersen, N., Gramatica, A., Loew, M., Liebscher, J., Herrmann, A., Egger, H., Budde, B., & Arbuzova, A. (2011) · Langmuir · doi:10.1021/la201160y · Cited by 64
Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome
Xiao, W., Chen, X., Li, Y., Mao, Y.-Q., Wei, Y., & Chen, L. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.018 · Cited by 60
Apte, A., Koren, E., Koshkaryev, A., & Torchilin, V. P. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.26609 · Cited by 60
Self-citationChiu, G. N. C., Edwards, L., Kapanen, A. I., Malinen, M. M., Dragowska, W. H., Warburton, C., Chikh, G., Fang, K. Y. Y., Tan, S., Sy, J., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0159 · Cited by 59
Kenny, G. D., Bienemann, A. S., Tagalakis, A. D., Pugh, J., Welser, K., Campbell, F., Tabor, A. B., Hailes, H. C., Gill, S., Lythgoe, M. F., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.081 · Cited by 56
Hyperthermia induced targeting of thermosensitive gene carriers to tumors
Schwerdt, A., Zintchenko, A., Concia, M., Roesen, N., Fisher, K., Lindner, L. H., Issels, R. D., Wagner, E., & Ogris, M. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.064 · Cited by 54
Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition
Koshkaryev, A., Piroyan, A., & Torchilin, V. P. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.06.008 · Cited by 54
Self-citationLipoplatin Treatment in Lung and Breast Cancer
Fantini, M., Gianni, L., Santelmo, C., Drudi, F., Castellani, C., Affatato, A. A., Nicolini, M., & Ravaioli, A. (2010) · Chemotherapy Research and Practice · doi:10.1155/2011/125192 · Cited by 53
Vader, P., van der Aa, L. J., Engbersen, J. F. J., Storm, G., & Schiffelers, R. M. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0344-y · Cited by 53
Ayen, W. Y., & Kumar, N. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0783-8 · Cited by 51
Chen, J., Xing-fa, K., He, Z., Gong, H. F., Zhang, Y., Yao, J., Deng, L. F., Yang, D., & Jing, X. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s34801 · Cited by 49
Liposome technology for cardiovascular disease treatment and diagnosis
Bowey, K., Tanguay, J., & Tabrizian, M. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.647908 · Cited by 48
Nanomedicine in cardiovascular therapy: recent advancements
Binsalamah, Z. M., Paul, A., Prakash, S., & Shum‐Tim, D. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.41 · Cited by 48
Chiu, G. N. C., Chaudhury, Das, & Bunte (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s26172 · Cited by 45
Targeting of lysosomes by liposomes modified with octadecyl-rhodamine B
Koshkaryev, A., Thekkedath, R., Pagano, C., Meerovich, I. G., & Torchilin, V. P. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2010.550921 · Cited by 43
Self-citationNanomedicines for Treatment of Viral Diseases
Mehendale, R., Joshi, M. D., & Patravale, V. B. (2013) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2013005469 · Cited by 41
Sawant, R., Sawant, R. R., Gultepe, E., Nagesha, D. K., Papahadjopoulos‐Sternberg, B., Sridhar, S., & Torchilin, V. P. (2009) · Journal of Nanoparticle Research · doi:10.1007/s11051-009-9611-4 · Cited by 41
Self-citationIverson, N. M., Sparks, S. M., Demirdirek, B., Uhrich, K. E., & Moghe, P. V. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.02.019 · Cited by 39
Conjugation of paclitaxel to iron oxide nanoparticles for tumor imaging and therapy
Liu, D., Wu, W., Chen, X., Wen, S., Zhang, X., Ding, Q., Teng, G., & Gu, N. (2012) · Nanoscale · doi:10.1039/c2nr11918h · Cited by 38
Adrian, J. E., Morselt, H. W. M., Süss, R., Barnert, S., Kok, J., Ásgeirsdóttir, S. A., Ruiters, M. H. J., Molema, G., & Kamps, J. A. A. M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.003 · Cited by 38
Surface-modified liposomes in gamma- and MR-imaging
Torchilin, V. P. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00472-3 · Cited by 36
Self-citationSy, J. C., & Davis, M. E. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9210-x · Cited by 34
Li, S., Zhang, Y., Huang, Zhang, Gao, & Gibbs (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s31981 · Cited by 33
Jeong, J. H., Kim, S. H., Christensen, L. V., et al. (2010) · Bioconjugate Chemistry · doi:10.1021/bc9003525 · Cited by 33
Wang, F. H., Kim, D. K., Yoshitake, T., Johansson, S. M., Bjelke, B., Muhammed, M. A., & Kehr, J. (2010) · Nanotechnology · doi:10.1088/0957-4484/22/1/015103 · Cited by 24
Saif, M. W. (2014) · PubMed · doi:10.6092/1590-8577/2507 · Cited by 16
Cited by
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Liposomal Formulations in Clinical Use: An Updated Review
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,156
The Effect of Nanoparticle Size on In Vivo Pharmacokinetics and Cellular Interaction
Hoshyar, N., Gray, S., Han, H., & Bao, G. (2016) · Nanomedicine · doi:10.2217/nnm.16.5 · Cited by 1,990
New developments in liposomal drug delivery
Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600
Self-citationSmart micro/nanoparticles in stimulus-responsive drug/gene delivery systems
Karimi, M., Ghasemi, A., Sahandi Zangabad, P., Rahighi, R., Moosavi Basri, S. M., Mirshekari, H., Amiri, M., Shafaei Pishabad, Z., Aslani, A., Bozorgomid, M., et al. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00798d · Cited by 1,519
Metadata
- Authors
- Torchilin, V. P.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2014-10-07
- Volume
- 13
- Issue
- 11
- Pages
- 813-827
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2094305477
- Cited by
- 1,663
- References
- 197
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.